Skip to main content
2025 STS Annual Meeting Main banner

General Thoracic

Multimodal Treatment of Pleural Mesothelioma after the MARS-2 trial: Will We Change Our Ways?

Saturday, January 25, 2025
10:15am - 11:45am PT
Location: 408A

    Moderator(s)

  • Boris Sepesi, MD

    Director of Thoracic Surgery and Thoracic Surgical Oncology
    Sarah Cannon Cancer Network at Swedish Medical Center, Englewood, Colorado
    Englewood, Colorado, United States

    Disclosure(s): No financial relationships to disclose

  • Ian Bostock, MD MS

    Associate Professor
    Miami Cancer Institute
    Miami, Florida, United States

    Disclosure(s): No financial relationships to disclose

Disclosure(s):
Boris Sepesi, MD: No financial relationships to disclose
Ian C. Bostock, MD MS: No financial relationships to disclose

Presentations:

  • 10:15am - 10:23am PT
    The New IASLC TNM Pleural Mesothelioma Staging and Its Effect on Treatment Options

    Invited Speaker: Valerie Rusch, MD (she/her/hers) – Memorial Sloan Kettering Cancer Center

  • 10:23am - 10:31am PT
    The Role of Pleurectomy and Decortication in Pleural Mesothelioma: How I Do It

    Invited Speaker: Andrea Wolf, MD, MPH (she/her/hers) – The Icahn School of Medicine at Mount Sinai

  • 10:31am - 10:39am PT
    Novel Perioperative Analgesia Modalities During Pleurectomy and Decortication for Pleural Mesothelioma

    Invited Speaker: Jeffrey B. Velotta, MD, FACS – Kaiser Permanente Oakland Medical Center, UCSF Department of Surgery, Kaiser Permanente Bernard J. Tyson School of Medicine

  • 10:39am - 10:50am PT
    Panel Discussion
  • 10:50am - 11:00am PT
    Updated Post-Recurrence Survival Outcomes in Patients Undergoing Pleurectomy/Decortication for Pleural Mesothelioma

    Presenting Author: Akifumi Nakamura, PhD MD (he/him/his) – Hyogo Medical University

  • 11:00am - 11:10am PT
    Prolonged Survival is Possible in Mesothelioma Patients Managed Non-Operatively: A National Cancer Database Analysis

    Presenting Author: Peter L. Zhan, MD – Yale University

  • 11:10am - 11:18am PT
    Neoadjuvant Immunotherapy in the Treatment of Pleural Mesothelioma

    Invited Speaker: Bryan M. Burt, MD – University of California, Los Angeles

  • 11:18am - 11:26am PT
    Adjuvant Systemic and Immunotherapy Options in the Treatment of Pleural Mesothelioma

    Invited Speaker: Jennifer Marie Suga, MD MPH (she/her/hers) – The Permanente Medical Group

  • 11:26am - 11:45am PT
    Panel Discussion